| Financial Year |
March 31 2023 |
| Monetary Funds |
4,107,103,681.89 |
| Held-for-trading Financial Assets |
-- |
| Notes Receivable |
1,141,789,325.32 |
| Accounts Receivable |
8,969,952,724.39 |
| Advances to Suppliers |
4,223,921,397.17 |
| Other Receivables |
220,914,488.13 |
| Amounts Due From Related Companies |
-- |
| Interest Receivable |
-- |
| Dividend Receivable |
220,819.44 |
| Inventories |
19,075,984,468.17 |
| Among: Consumptive Biological Assets |
-- |
| Non-Current Assets Maturing Within One Year |
-- |
| Other Current Assets |
417,913,811.40 |
| Total Current Assets |
38,183,691,177.78 |
| Available-for-Sale Financial Asset |
-- |
| Held-to-maturity Investments |
-- |
| Long-Term Account Receivable |
-- |
| Long-term Equity Investment |
-- |
| Investment Properties |
64,321,233.70 |
| Fixed Assetes |
4,599,362,332.85 |
| Under-construction Projects |
509,860,149.08 |
| Construction Materials |
-- |
| Disposal of Fixed Assets |
-- |
| Capitalized Biological Assets |
-- |
| Oil and Gas Assets |
-- |
| Intangible Assets |
1,078,107,132.06 |
| R&D expenses |
340,275,761.92 |
| Goodwill |
-- |
| Long-Term Deferred and Prepaid Expenses |
27,514,081.36 |
| Deferred Income Tax Assets |
69,235,156.11 |
| Other Non-Current Assets |
-- |
| Sub-Total of Non-Current Assets |
6,968,814,939.06 |
| Total Assets |
45,152,506,116.84 |
| Short-Term Loans |
5,811,000,000.00 |
| Trading Financial liabilities |
-- |
| Notes Payable |
4,140,607,305.93 |
| Accounts Payable |
9,812,979,171.37 |
| Accounts Received In Advance |
-- |
| Employee Compensation Payable |
333,311,638.70 |
| Taxes Payable |
79,561,441.81 |
| Interest Payable |
-- |
| Dividend Payable |
34,703,048.06 |
| Other payables |
595,967,164.30 |
| Due to Related Companies |
-- |
| Non-Current Liabilities Due Within One Year |
81,087,176.80 |
| Other Current Liabilities |
1,826,898,213.95 |
| Sub-Total of Current Liabilities |
24,920,758,430.66 |
| Long-term Loans |
390,000,000.00 |
| Bonds Payable |
-- |
| Long-Term Accounts Payable |
7,926,441.58 |
| Special Payable |
-- |
| Estimatied Liabilities |
-- |
| Deferred Income Tax Liabilities |
7,758,505.72 |
| Other Non-Current Liabilities |
-- |
| Sub-Total of Non-Current Liabilities |
853,132,404.06 |
| Total Liabilities |
25,773,890,834.72 |
| Paid-In Capital(Or Share Stock) |
2,719,271,284.00 |
| Capital Surplus |
6,552,506,793.61 |
| Surplus Reserve |
148,731,503.83 |
| LESS:Treasury Stock |
-- |
| Undistributed Profits |
6,211,823,823.19 |
| Minority Stockholder's Interest |
3,540,913,692.88 |
| Foreign Currency Capital |
-- |
| Abnormal Management Project Income Adjusted |
-- |
| Total Owners' Equity Attributable to Parent(Stockholder's Interest) |
15,837,701,589.24 |
| Owner's Equity（Stockholder's Equity） |
19,378,615,282.12 |
| Total Liabilities and Owner's Equity（Stockholder's Equity） |
45,152,506,116.84 |
